疫苗前沿 | 預防老年人嚴重呼吸道疾病效力為80%,楊森RSV疫苗達到2b期臨床終點
com/janssen-announces-start-phase-3-trial-investigational-respiratory-syncytial-virus-rsv-vaccine-older[2] Janssen Annou...
com/janssen-announces-start-phase-3-trial-investigational-respiratory-syncytial-virus-rsv-vaccine-older[2] Janssen Annou...